Paradigm Biopharmaceuticals Ltd.ASX: PAR

Notification regarding unquoted securities - PAR

Sep 10, 2026 at 10:32 PM EDT · Issued by Paradigm Biopharmaceuticals Ltd. via ASX

Filed with ASX · Sep 10, 2026 at 10:32 PM EDT

On 6ix: 6ix.com/news/notification-regarding-unquoted-securities-par

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securitiesAppendix 3G - Notification of issue, conversion or payment up of unquoted equity securities1 / 5Announcement SummaryEntity namePARADIGM BIOPHARMACEUTICALS LIMITED..Date of this announcementFriday September...

View Attachment

6ix hasn’t read this filing yet.

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

Drawdown of Tranche 4 under the Convertible Note FacilitySep 10
Application for quotation of securities - PARSep 10
Melbourne Investor LunchSep 2
Appendix 4E and 2026 Annual ReportAug 27
Appendix 4G and Corporate Governance StatementAug 27

Later from Paradigm Biopharmaceuticals

Notice under Section 708ASep 10
Dr Daniel Furtner appointed Chief Medical OfficerSep 14
Trading HaltSep 20
Suspension from QuotationSep 22
Phase 3 Interim Result Below Continuation ThresholdSep 23

All Paradigm Biopharmaceuticals news releases

Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.

Follow Paradigm Biopharmaceuticals